Skip to Main Content

Paper Details

Homoharringtonine exhibits potent anti-tumor effect and modulates DNA epigenome in acute myeloid leukemia by targeting SP1/TET1/5hmC.
Haematologica
37
2020
5, 5hmC, AML, DNA epigenome, FLT3, FLT3 mutations, FLT3-mutated AML cells, Homoharringtonine, MYC, RNA, SP1, TET1, acute myeloid leukemia, chronic myeloid leukemia, homoharringtonine, human, mice, murine, murine or human AML
Author NameAffiliation
Hao HuangFeinberg School of Medicine, Northwestern University
  • 1 - 1

Datasets

Release 1.2